Watershed Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,695
Closed -$270K 117
2023
Q1
$270K Sell
1,695
-42
-2% -$6.42K 0.33% 62
2022
Q4
$281K Buy
1,737
+122
+8% +$18.7K 0.36% 24
2022
Q3
$217K Sell
1,615
-179
-10% -$25.7K 0.28% 96
2022
Q2
$275K Buy
1,794
+103
+6% +$15.7K 0.34% 22
2022
Q1
$274K Sell
1,691
-312
-16% -$45.3K 0.28% 53
2021
Q4
$271K Buy
+2,003
New +$237K 0.24% 91

Other funds holding ABBV

Watershed Asset Management's ABBV Position: Q2 2023 in Review

Watershed Asset Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,695 shares — an estimated $270K sold.

Watershed Asset Management first reported a position in ABBV in Q4 2021 and held it in 6 quarters. The position peaked at $281K in Q4 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Watershed Asset Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Watershed Asset Management sold 1,695 AbbVie shares in Q2 2023, an estimated $270K.
  • Watershed Asset Management first reported a position in AbbVie in Q4 2021 and held it in 6 quarters.
  • Watershed Asset Management's AbbVie position peaked at $281K in Q4 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Watershed Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.